CareDx, Inc (CDNA) vs Celcuity Inc. (CELC)
A side-by-side comparison of CareDx, Inc and Celcuity Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDNA
CareDx, Inc
$64.53HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
CELC
Celcuity Inc.
$71.49HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — CDNA vs CELC
growth of $100 · dividends reinvested · last 9yCDNA +2403.6% (+43.0%/yr)CELC +415.2% (+20.0%/yr)CDNA compounded faster over this window
CDNA CELC
CDNA vs CELC: by the numbers
- •CELC is the larger company ($3.49B vs $3.34B market cap).
- •CDNA is profitable (24.23% net margin) while CELC runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CDNA | CELC |
|---|---|---|
| P/E ratio | 31.16 | N/A |
| Forward P/E | 53.88 | N/A |
| P/S ratio | 7.29 | N/A |
| P/B ratio | 7.84 | N/A |
| EV / EBITDA | 191.80 | N/A |
| FCF yield | 2.55% | N/A |
Profitability
| Metric | CDNA | CELC |
|---|---|---|
| Gross margin | 70.58% | 0.00% |
| Operating margin | -0.92% | 0.00% |
| Net margin | 24.23% | 0.00% |
| ROE | 26.08% | N/A |
| ROIC | -0.93% | -28.15% |
Growth (annualized)
| Metric | CDNA | CELC |
|---|---|---|
| Revenue CAGR (5Y) | 12.56% | N/A |
| Total return CAGR (5Y) | 1.33% | 34.40% |
Frequently asked
- Is CDNA or CELC more profitable?
- CDNA runs the higher net margin — CDNA at 24.23% versus CELC at 0.00%.
- How have CDNA and CELC total returns compared?
- Over the past 5 years, CDNA delivered 1.33% and CELC delivered 34.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CareDx P/E ratioCareDx ROECelcuity ROECareDx operating marginCelcuity operating marginCareDx revenue growthCelcuity revenue growthCareDx free cash flowCelcuity free cash flow
CareDx & Celcuity appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.